Literature DB >> 23972262

ALADIN: wish granted in inherited polycystic kidney disease?

Qi Qian1, Hai Yan Wang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23972262      PMCID： PMC4054814          DOI： 10.1016/S0140-6736(13)61541-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Bending the MDCK cell primary cilium increases intracellular calcium.

Authors:  H A Praetorius; K R Spring
Journal:  J Membr Biol       Date:  2001-11-01       Impact factor: 1.843

Review 2.  Autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris; Yves Pirson
Journal:  Lancet       Date:  2007-04-14       Impact factor: 79.321

3.  Pharmacokinetics, pharmacodynamics, and safety of microencapsulated octreotide acetate in healthy subjects.

Authors:  T Chen; T F Miller; P Prasad; J Lee; J Krauss; K Miscik; G Kalafsky; J F McLeod
Journal:  J Clin Pharmacol       Date:  2000-05       Impact factor: 3.126

4.  Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease.

Authors:  Piero Ruggenenti; Andrea Remuzzi; Patrizia Ondei; Giorgio Fasolini; Luca Antiga; Bogdan Ene-Iordache; Giuseppe Remuzzi; Franklin H Epstein
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

5.  Long-term octreotide treatment of metastatic carcinoid tumor.

Authors:  V D Corleto; S Angeletti; O Schillaci; M Marignani; M Caratozzolo; F Panzuto; B Annibale; G Delle Fave
Journal:  Ann Oncol       Date:  2000-04       Impact factor: 32.976

Review 6.  The pathophysiological consequences of somatostatin receptor internalization and resistance.

Authors:  Leo J Hofland; Steven W J Lamberts
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

7.  Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly.

Authors:  S M Catnach; J V Anderson; P D Fairclough; R C Trembath; P A Wilson; E Parker; G M Besser; J A Wass
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

8.  Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.

Authors:  Tamio Yamaguchi; Shizuko Nagao; Darren P Wallace; Franck A Belibi; Benjamin D Cowley; Jill C Pelling; Jared J Grantham
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

Review 9.  Molecular properties of somatostatin receptors.

Authors:  T Reisine; G I Bell
Journal:  Neuroscience       Date:  1995-08       Impact factor: 3.590

10.  Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.

Authors:  Anna Caroli; Norberto Perico; Annalisa Perna; Luca Antiga; Paolo Brambilla; Antonio Pisani; Bianca Visciano; Massimo Imbriaco; Piergiorgio Messa; Roberta Cerutti; Mauro Dugo; Luca Cancian; Erasmo Buongiorno; Antonio De Pascalis; Flavio Gaspari; Fabiola Carrara; Nadia Rubis; Silvia Prandini; Andrea Remuzzi; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  Lancet       Date:  2013-08-21       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.